Shared decision making is the foundation of modern patient-centred care and is key to overcoming patient- and clinical-level barriers to opiate agonist therapy (OAT) uptake and retention in treatment. Newly available depot buprenorphine products offer expanded choice in treatment modality. However, as the effectiveness and cost-effectiveness of policy decisions may be compromised by patient preferences, […]

Relapse prevention is about building the capacity of individuals to maintain and sustain positive changes with their substance use. This Zoom workshop is designed for practitioners who provide direct support to people with AOD concerns who wish to better understand and communicate strategies, tools and techniques that can help someone stay in recovery through the prevention […]

This Zoom session targets practitioners working in specialist alcohol and drug and mental health settings who want to develop an in-depth neurobiological understanding of how psychoactive substances affect the brain and body.  It is the first session of a 2-part workshop. By the end of this session learners will be able to: Classify different drugs […]

Part A: 9.00am – 1.00pm, Tuesday, 7 September 2021 Part B: 9.00am – 1.00pm, Tuesday, 14 September 2021 Mindfulness is a specialised skill in awareness, attention, and acceptance. There is ever increasing evidence of the benefits of mindfulness based interventions within alcohol and drug treatment for stress reduction, craving management and relapse prevention. The aims of this […]

We have all experienced patient interactions in practice which leave us uncomfortable and or questioning our clinical decision making. Commonly these scenarios involve patients who live with complex care needs and are prescribed medicines known to have a high-risk of harm. Our expert panel will unpack several tricky practice scenarios and provide advice on how […]